A

Applied Therapeutics
D

APLT

0.85210
USD
-0.02
(-2.73%)
Market Closed
Volume
55,137
EPS
-1
Div Yield
-
P/E
-1
Market Cap
99,147,351
OverviewSignalsIdeasNews
Related Instruments
    A
    APDN
    0.00910
    (5.32%)
    0.18000 USD
    A
    APT
    0.13000
    (2.49%)
    5.35000 USD
    A
    APTO
    -0.01170
    (-4.87%)
    0.22840 USD
    A
    APTV
    0.410
    (0.69%)
    59.880 USD
    A
    APTX
    0
    (0%)
    0.000000 USD
    More
News

Title: Applied Therapeutics

Sector: Healthcare
Industry: Biotechnology
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.